Skip to content
Disclosery

13F-HR filed by DC Funds, LP

DC Funds, LP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 3 holding rows worth $6,633,000.

Accession
0001398344-22-022155
Filer
CIK 1869028
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A combination report, 3 entries on the cover page, a total value of $6,633,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $6,634,000 with VALUE read as thousands by filing date, 13F file number 028-21338. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WEREWOLF THERAPEUTICS INC95075A107CMN589,102$2,657,000thousands by filing date
BARINTHUS BIOTHERAPEUTICS PL91864C107ADS642,204$2,055,000thousands by filing date
Tscan Therapeutics Inc89854M101COM630,000$1,922,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001398344-22-022155this filing2022-11-14acceptance time not in the bulk data set